Chromic Phosphate

CHEMBL2110568 Phase 4 Aprovado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
147.0 g/mol
LogP
Phase
4

An inorganic phosphate salt of chromium used as a colloidal suspension in radiation therapy and as a component in parenteral nutrition. The radioactive phosphorus-32 form is used for intraperitoneal or intrapleural instillation to treat malignant effusions. Non-radioactive forms are occasionally used in specialized research and diagnostic contexts.

Peso Molecular

146,9670 g/mol

TPSA

86,30 Ų

Mecanismo de Ação

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mecanismo

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

Estrutura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

[O-]P(=O)([O-])[O-].[Cr+3]

InChI

InChI=1S/Cr.H3O4P/c;1-5(2,3)4/h;(H3,1,2,3,4)/q+3;/p-3

Molecular Formula

CrO4P

HBD / HBA

- / 4

Ligações Rotacionáveis

0

Átomos Pesados

6

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

An inorganic phosphate salt of chromium used as a colloidal suspension in radiation therapy and as a component in parenteral nutrition. The radioactive phosphorus-32 form is used for intraperitoneal or intrapleural instillation to treat malignant effusions. Non-radioactive forms are occasionally used in specialized research and diagnostic contexts.

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

Yes, Chromic Phosphate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2110568. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 62673. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.